Showing results (221-230 of 523) with videos related to
Sort By:
Pageof 53
Targeted Oncology|August 15, 2014
Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLCCecile Bosc, Gilbert R Ferretti, Jacques Cadranel, et al.Lung Cancer (Amsterdam, Netherlands)|October 7, 2019
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancerBenjamin Besse, Fabrice Barlesi, Ingel Demedts, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 26, 2011
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTLAurélie Durgeau, Faten El Hage, Isabelle Vergnon, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2014
Synaptic release of CCL5 storage vesicles triggers CXCR4 surface expression promoting CTL migration in response to CXCL12Katarzyna Franciszkiewicz, Marie Boutet, Ludiane Gauthier, et al.Respiratory Medicine and Research|November 12, 2022
Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitorsMarion Camard, Benjamin Besse, Pierre-Louis Cariou, et al.Cancers|March 13, 2024
Thermal Ablation Combined with Immune Checkpoint Blockers: A 10-Year Monocentric ExperienceBaptiste Bonnet, Louis Tournier, Frédéric Deschamps, et al.Future Oncology (London, England)|August 2, 2021
Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challengesXabier Mielgo-Rubio, Margarita Martín, Jordi Remon, et al.Cancers|January 11, 2022
Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort ExperienceTina Lamy, Bastien Cabarrou, David Planchard, et al.European Journal of Cancer (Oxford, England : 1990)|April 8, 2023
Electrochemotherapy in radiotherapy-resistant epidural spinal cord compression in metastatic cancer patientsFrederic Deschamps, Lambros Tselikas, Steven Yevich, et al.Oncoimmunology|July 4, 2025
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancerLéa Montégut, Adrien Rousseau, Cinzia Ungolo, et al.Pageof 53